Studies of the immunomodulatory effects of low-level infection with Ostertagia ostertagi in calves

Possible immunomodulation by low-level infection with Ostertagia ostertagi was studied in 4-month-old calves. Six groups of 4 calves each were subjected to the following regimens: group 1--nonparasitized controls; group 2--nonparasitized, but challenge exposed at day 64 with Brucella abortus strain 19 vaccine (BA) and at day 78 with IV administration of a soluble third-stage larval (L3) antigen preparation of O ostertagi (OAG); group 3--nonparasitized, but challenge exposed at day 78 with 75 x 10(3) L3 of O ostertagi; group 4--continuously parasitized by weekly dosing with 30 x 10(3) L3 of O ostertagi; group 5--continuously parasitized by weekly dosing with 30 x 10(3) L3 of O ostertagi, then challenge exposed on day 64 with BA and on day 78 with IV inoculation of OAG; and group 6--continuously parasitized by weekly dosing with 30 x 10(3) L3 of O ostertagi, then challenge exposed on day 78 with 75 x 10(3) L3 of O ostertagi. Over the initial 10 weeks of the study, nonparasitized calves, (groups 1, 2, and 3) had higher body weight, blood lymphocyte (BL) response to phytohemagglutinin (PHA), and significantly (P less than 0.05) higher feed consumption and lymphocyte numbers, whereas parasitized calves (groups 4, 5, and 6) had higher BL responses to pokeweed mitogen (PWM) and significantly (P less than 0.05) higher neutrophil and eosinophil numbers, plasma pepsinogen (PP) values, and BL response to OAG.(ABSTRACT TRUNCATED AT 250 WORDS)     

合理使用抗球虫药物及肉鸡球虫病的控制

各日龄的肉鸡对球虫都是敏感的。球虫为单性、细胞内寄生的原虫,发育无需中间宿主,繁殖力极强。虽然从40年代初开始应用磺胺类药物来治疗、预防球虫病,随后又涌现出了一大批不同类型的抗球虫药物,从而使鸡球虫病已不再是毁火性的,但球虫病也并未因此而得到完全控制。相反,在世界范围内,随着集约化养殖业的迅速发展,由球虫病所造成的损失也相应地逐年增     

Bovine adenovirus type-3 infection in feedlot calves

The frequency of bovine adenovirus type-3 (BA3) infection in 84 of 165 light feeder calves and the possible role of BA3 in inducing febrile disease and affecting weight gain performance were studied for 56 days after the calves entered a feedlot. Samples of blood for serotesting were obtained periodically, and samples for virus isolation were collected on days 28 and 56. At the time the calves entered the feedlot, 17.8% (15 of 84) had serum virus-neutralizing antibodies to BA3. During 56 days, 54.8% (46 of 84) seroconverted to BA3. Of these seroconversions, 87% took place during the first 28 days. Bovine adenovirus type-3 was isolated from 2 calves (1 isolate each on days 28 and 56). Pyrexia (greater than or equal to 39.2 C) was observed more often in BA3-infected calves than in noninfected calves. However, there was no significant (P less than 0.05) difference in weight gain between the BA3-infected and noninfected calves.     

Immunostimulatory and protective effects of Aloe vera against coccidiosis in industrial broiler chickens

This paper reports the immunostimulatory and protective effects of Aloe vera extracts (aqueous and ethanolic) against coccidiosis in industrial broiler chickens. The study was divided into two experiments. Experiment-I was conducted for the evaluation of immunostimulatory activity of A. vera and experiment-II demonstrated the protective efficacy of A. vera extracts against coccidiosis in chickens. Results of the experiment-I revealed significantly higher (p<0.05) lymphoproliferative responses in chickens administered with ethanolic extract of A. vera as compared to those administered with aqueous extract and control group. Microplate haemagglutination assay for humoral response on day 7th and 14th post primary and secondary injections of sheep red blood cells (SRBCs) revealed significantly higher (p<0.05) anti SRBC antibody (total Igs, IgG and IgM) titers in chickens of experimental groups as compared to the control group. None of the extracts, however, demonstrated significant effects on the development of lymphoid organs. Results of experiment-II revealed maximum protection (60%) in chickens administered with aqueous Aloe extract as compared to the ethanolic extract administered chickens (45%). Mean oocysts per gram of droppings in the control group was significantly higher (p<0.05) as compared to the chickens in both the experimental groups. Chickens administered with aqueous Aloe extract showed a minimal mean lesion score (2.3) followed by those administered with ethanolic Aloe extract (2.6) and control chickens (3.05) for caeca, and a similar pattern was observed for intestinal lesion scoring. Further, significantly higher weight gains and antibody titers (p<0.05) were observed in chickens administered with A. vera extracts as compared to those in the control group. It was concluded that A. vera may be a potential and valuable candidate to stimulate the immune responses and can be used successfully as an immunotherapeutic agent against coccidiosis in industrial broiler chickens.     

Bovine respiratory disease: efficacy of different prophylactic treatments in veal calves and antimicrobial resistance of isolated Pasteurellaceae

The present study was conducted to evaluate the efficacy of two prophylactic antibiotic treatments against bovine respiratory disease (BRD) in veal calves. In addition, the antibiotic susceptibilities of isolated Pasteurellaceae were tested. The calves were treated either on the day of arrival by a single administration of tulathromycin (group A, n = 20), by a peroral administration of chlortetracycline, sulphadimidine, and tylosin (group B, n = 20) for seven consecutive days, or were not prophylactically treated (group C, n = 19). On the first day of clinically diagnosed BRD, transtracheal lavage samples were obtained prior to therapeutic treatment and were subsequently cultured. Pasteurellaceae isolates were tested for their susceptibility to 12 antimicrobial agents by the determination of the minimal inhibitory concentrations. During the first 56 d after arrival, different calves in group A and B suffered from one episode of clinically diagnosed BRD while calves of group C experienced two episodes. The average daily weight gain during the same period was significantly lower in group C (0.89 ± 0.04 kg/d) than in the two prophylactically treated groups (1.14 ± 0.05 and 1.15 ± 0.04 kg/d for group A and B, respectively). The improved performance of groups A and B in comparison to group C could be related to a lower incidence of respiratory disorders during the first days after arrival in the prophylactically treated animals. No differences in the clinical efficacy were seen between the two tested prophylactic treatments. The most prevalent bacterial pathogens isolated (n = 79) were Pasteurella multocida (23% of isolated pathogens), Mycoplasma bovis (18%), and Mannheimia varigena (16%). For the isolated Pasteurellaceae, a high resistance pattern was observed to tylosin (83% of the tested P. multocida and 88% of the Mannheimia spp. isolates resistant) and tilmicosin (56% of the tested P. multocida isolates non-sensitive).     

Control of bovine coccidiosis with monensin: in nonresistant newborn calves

Newborn Holstein male calves were purchased within 3 days after birth and were removed from the local farms to the Dixon Springs Agricultural Research Center. They were hand-fed for 7 weeks and then weaned to a prepared feed. Eight groups, each of 4 calves, were housed in separate pens. In each of 4 pens (pens 2 to 5), 1 calf was inoculated with sporulated oocysts of Eimeria bovis (and was not medicated); 1 calf was inoculated and given feed with added monensin at the dosage level of 10 g/906 kg of feed; and 2 calves were inoculated and given medicated feed with added monensin at the dosage level of 20 g/906 kg or 30 g/906 kg. In the 4 other pens (6 to 9), the calves were inoculated with E zuernii and otherwise were given feed without or with added monensin as in pens 2 through 5. Another group of 5 calves (all kept in 1 pen), served as noninoculated, nonmedicated controls. At 14 days after inoculations with E bovis, the single calves in each of the 4 pens that were given the nonmedicated feed began to show clinical signs of coccidiosis and discharged increasing numbers of oocysts. The other inoculated calves (given monensin) had fewer clinical signs and discharged fewer oocysts in the feces as the level of medication in the feed increased. The calves inoculated with E zuernii developed only moderately severe infections when compared with those inoculated with E bovis. Inoculated (with E bovis) nonmedicated calves had severe reductions in feed consumption and weight, and 3 of 4 died.(ABSTRACT TRUNCATED AT 250 WORDS)     

中草药制剂TF-103抗鸡柔嫩艾美尔球虫病的临床试验

鸡球虫病是一种广泛而危害性极大的寄生虫病,特别是雏鸡的发病率、死亡率都较高.目前该病的防治主要依赖化学药物,但由于使用化学药物病原体易产生耐药性,且在可食性产品中的药物残留会危害人类的健康.因此,人们愈来愈重视毒副作用相对较小的、使用安全的中草药抗球虫制剂.TF-103是一种以中药白头翁(Pulsatilla chinensis)为主药组成的纯中药抗球虫方剂.在反复筛选及正交试验优化组方的基础上,经多次药效学和工艺学研究开发的新型中药抗球虫产品,本品毒性极低[1,2],且抗鸡球虫活性稳定.本次试验是在前期工作的基础上,对三批中试产品进行了抗鸡柔嫩艾美尔球虫病的临床放大试验研究,目的是为了验证生产工艺的稳定性和临床应用的有效性.     

Evaluation of lasalocid as a coccidiostat in calves: titration, efficacy, and comparison with monensin and decoquinate

Two experiments were conducted to evaluate lasalocid as a coccidiostat in Holstein calves and to compare lasalocid with monensin and decoquinate. In experiment 1, calves in 3 groups (6 calves/group) were each inoculated with 500,000 sporulated oocysts, 88% of which were Eimeria bovis and 12% were E zuernii. Calves in each group were given lasalocid-medicated feed at 0.50 (group 3), 0.75 (group 4), or 1 mg/kg (group 5) of body weight/day for 45 days. Two control groups (6 calves/group) were also evaluated; calves in control group 2 were inoculated and nontreated, and calves in control group 1 were noninoculated and nontreated. At 0.50, 0.75, or 1 mg/kg/day, lasalocid was equally effective in preventing induced coccidiosis (E bovis and E zuernii) in calves. Compared with inoculated nontreated controls, treated calves had significantly (P less than 0.05) fewer oocysts in feces and had fewer clinical signs of coccidiosis from days 16 to 30 after inoculation. Experiment 2 was conducted to compare the effectiveness of monensin, lasalocid, and decoquinate for the prevention of experimentally induced coccidiosis. Calves (n = 48) were allotted into 4 groups (12 calves/group); each was inoculated orally with 275,000 sporulated oocysts, predominantly E bovis and E zuernii, and each was given nonmedicated feed (group 6) or feed medicated with 33 mg of lasalocid (group 7), decoquinate (group 8), or monensin (group 9)/kg of feed for 46 days. Calves given medicated rations had significantly (P less than 0.05) fewer oocysts in their feces and fewer clinical signs of coccidiosis than did calves given nonmedicated rations.(ABSTRACT TRUNCATED AT 250 WORDS)     

Bovine lymphosarcoma in twin calves.

Lymphosarcoma in twin female calves, apparently the first to be observed in Canada, is reported here. Peripheral blood and cultured mononuclear cells of one of the calves showed aneuploidy of the chromosomes. No hematological or serological evidence of bovine leukemia virus infection was observed in the other members of the herd. Bovine leukemia virus infection of the leukemic cells could not be detected by electron microscopy or by tissue culture procedures. There is a need to clarify the relationship of the calf form of the disease to the adult form of enzootic bovine leukosis.     

Treatment with toltrazuril in a natural outbreak of coccidiosis in calves

Treatment with toltrazuril (Baycox) in calves naturally infected with several enteropathogenic agents resulted in a reduction in the mean number of Eimeria oocysts shed. The mean faecal consistency for the treated calves also differed significantly from that of the untreated calves. There was virtually no difference in weight gain in the two groups.     

Use of Artemisia annua as a natural coccidiostat in free-range broilers and its effects on infection dynamics and performance

This work investigated the preventive effect of Artemisia annua L. dried leaves supplied as a botanical coccidiostat to two broiler genotypes reared in a Danish free-range system in a factorial experiment (two genotypes and ± supplement of dried A. annua leaves). The genotypes White Bresse L40, a pure slow-growing line, and Kosmos 8 Ross, a hybrid genotype with medium growing characteristics, were used. Broilers were raised indoor until 29-days-old and kept free of parasites. Twelve groups of 30 randomly selected broilers were placed in the range forming three replicates for each treatment combination. The paddocks were cultivated with a mix of grass and clover. A separate group of broilers was naturally infected with Eimeria spp. oocysts and five animals nominated as "seeders" were introduced to the above mentioned 12 groups, 10 days after its formation, with each group consisting of 35 animals per plot. This infection strategy was meant to imitate the transmission pathway observed at farm level. Ten individual birds from each of the 12 groups, in total 120 animals of mixed sex, were monitored twice weekly for 30 days for oocysts excretion. PCR of pooled faecal samples, oocyst morphology and localization upon necropsy were used to identify the Eimeria species involved in the infection. In general, broilers from both genotypes in the range coped well with a coccidia infection caused by Eimeria acervulina and Eimeria maxima as no clinical symptoms, or deaths, were reported during the experiment. In general, broilers supplemented with A. annua dried leaves showed a significantly (p<0.05) reduced number of excreted oocysts during the infection with no interaction to genotype. Females generally had a significantly higher shedding of oocysts than males (p<0.05). The overall body weight gain and the daily weight gain when infection was subdued showed a three-way interaction among genotype, sex and treatment - accounted mainly for the fact that Kosmos females responded positively to the Artemisia treatment while Kosmos males responded negatively, and only minor differences were found between sexes for the White Bresse genotype. In conclusion, supply of A. annua dried leaves as a botanical coccidiostat significantly reduced oocyst output in free ranged broilers and thus may form part of a strategy to prevent commercial losses.